Verve Therapeutics Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	8,728	7,847	3,664	3,797	4,934	1,866	Upgrade
Market Cap Growth	51.64%	114.20%	-3.51%	-23.05%	164.40%	-25.49%	Upgrade
Last Close Price	135.00	120.00	56.02	58.06	75.00	28.18	Upgrade
PE Ratio	13.17	13.01	9.72	11.57	18.28	9.53	Upgrade
PS Ratio	5.00	4.85	2.73	3.63	6.21	3.09	Upgrade
PB Ratio	2.96	2.83	1.70	2.18	3.45	1.72	Upgrade
Debt / Equity Ratio	0.12	0.16	0.29	0.14	0.16	0.23	Upgrade
Return on Equity (ROE)	-	25.63%	20.35%	21.61%	22.05%	20.49%	Upgrade
Return on Assets (ROA)	-	2.58%	1.88%	2.16%	2.35%	2.17%	Upgrade
Earnings Yield	7.58%	8.06%	10.83%	9.02%	5.62%	10.86%	Upgrade
FCF Yield	-20.81%	-27.09%	-65.45%	-93.40%	-52.02%	-62.51%	Upgrade
Dividend Yield	1.23%	-	-	-	0.44%	1.18%	Upgrade
Payout Ratio	19.56%	4.61%	5.00%	10.47%	10.40%	3.43%	Upgrade
Buyback Yield / Dilution	-0.10%	-	-	-	-	-0.03%	Upgrade
Total Shareholder Return	1.14%	-	-	-	0.44%	1.16%	Upgrade

Source: S&P Global Market Intelligence. Banks template. Financial Sources.